Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19

BACKGROUND: The clinical management of coronavirus disease 2019 (COVID-19) is dependent on understanding the underlying factors that contribute to the disease severity. In the absence of effective antiviral therapies, other host immunomodulatory therapies such as targeting inflammatory response are...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Allergy Clin Immunol Pract
Main Authors: Chang, De, Zhao, Peng, Zhang, Dawei, Dong, Jing-Hui, Xu, Zhe, Yang, Guang, Li, Bo-Yu, Liu, Hong-Xia, Li, Bo-An, Qin, Cheng-Feng, Peng, Xiao-Hua, Wang, Fu-Sheng, Xie, Li-Xin, Chen, Zhu, Dela Cruz, Charles S., Sharma, Lokesh, Qin, En-Qiang
Formato: Artigo
Idioma:Inglês
Publicado: American Academy of Allergy, Asthma & Immunology 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305869/
https://ncbi.nlm.nih.gov/pubmed/32574840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.06.015
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares